Switch theme
Sign up to access all valuation multiples
JZJ Chain Drugstore Corp is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
2004
n/a
Last FY Revenue $1.3B
Last FY EBITDA $157M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, JZJ Chain Drugstore achieved revenue of $1.3B and an EBITDA of $157M.
JZJ Chain Drugstore expects next 12-month revenue of XXX and NTM EBITDA of XXX
See JZJ Chain Drugstore valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | XXX | $461M | XXX | XXX | XXX |
| Gross Margin | XXX | 36% | XXX | XXX | XXX |
| EBITDA | XXX | $157M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 12% | XXX | XXX | XXX |
| EBIT | XXX | $50.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | 4% | XXX | XXX | XXX |
| Net Profit | XXX | $17.8M | XXX | XXX | XXX |
| Net Margin | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | $280M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, JZJ Chain Drugstore's stock price is CNY 23 (or $3).
JZJ Chain Drugstore has current market cap of CNY 3.5B (or $486M), and EV of CNY 7.3B (or $1.0B).
See JZJ Chain Drugstore trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $486M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, JZJ Chain Drugstore has market cap of $486M and EV of $1.0B.
JZJ Chain Drugstore's trades at 0.8x EV/Revenue multiple, and 6.4x EV/EBITDA.
Equity research analysts estimate JZJ Chain Drugstore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
JZJ Chain Drugstore's P/E ratio is not available.
See valuation multiples for JZJ Chain Drugstore and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $486M | XXX | $486M | XXX | XXX | XXX |
| EV (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 6.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 20.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 27.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 30.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJZJ Chain Drugstore's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
JZJ Chain Drugstore's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
JZJ Chain Drugstore's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for JZJ Chain Drugstore and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JZJ Chain Drugstore acquired XXX companies to date.
Last acquisition by JZJ Chain Drugstore was XXXXXXXX, XXXXX XXXXX XXXXXX . JZJ Chain Drugstore acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was JZJ Chain Drugstore founded? | JZJ Chain Drugstore was founded in 2004. |
| Where is JZJ Chain Drugstore headquartered? | JZJ Chain Drugstore is headquartered in China. |
| Is JZJ Chain Drugstore publicy listed? | Yes, JZJ Chain Drugstore is a public company listed on SHG. |
| What is the stock symbol of JZJ Chain Drugstore? | JZJ Chain Drugstore trades under 605266 ticker. |
| When did JZJ Chain Drugstore go public? | JZJ Chain Drugstore went public in 2020. |
| Who are competitors of JZJ Chain Drugstore? | Similar companies to JZJ Chain Drugstore include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of JZJ Chain Drugstore? | JZJ Chain Drugstore's current market cap is $486M |
| Is JZJ Chain Drugstore profitable? | Yes, JZJ Chain Drugstore is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
